Resource Hub
VIRTUAL TOUR
CONTACT US
Our Company
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Global Locations
Media & Events
Recognitions
Services
Small Molecules
Discovery (CRO)
Integrated Drug Discovery
Chemistry
Biology
BioSafety
Development & Manufacturing (CDMO)
Drug Substance
Drug Product
Analytical Development
Performance Chemicals
Custom Chemical Synthesis
Commercial Manufacturing
Large Molecules (Biologics)
Discovery (CRO)
Integrated Discovery
Biology
Molecular Biology
Antibody Discovery
Protein Sciences
Cell Line Development
Development & Manufacturing (CDMO)
Process Research & Development
Bioproduction
Developability & Analytics
GMP Manufacturing
Investors
Annual Reports and Annual Returns
Corporate Governance
IPO Documents
Our Responsibility
Digital & AI (DnA)
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Careers
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Virtual Tour
Resources
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH
Home
Biology
Page 4
Resource Science:
Biology
Exploring PROTAC Permeability: Comparative Insights Across Different Cell Lines
Reporter Cell Lines for Immuno-Oncology Drug Discovery: Targeting T-Cell Activation
Leveraging Surface Plasmon Resonance for Characterizing Ternary Complexes
Scalable Production of High-Purity Nanobodies Using Yeast Expression System
Pharmacokinetic (PK) solutions in large animals
Preclinical Evaluation of new Antifibrotics in IPF Rodent Models
Development of Covalent Drugs with New Emerging Technologies
Preclinical Evaluation of new Antifibrotics in NASH-Induced Fibrosis Models
Preclinical Evaluation of new Antifibrotics in Corona mouse Virus-Induced Fibrosis Model
Covalent Drugs – Advantages, Challenges, And Opportunities
1
2
3
4
5
6
7
Learn more about our end-to-end capabilities
+
+
